Inventiva S.A.
IVA • Biotechnology
$4.78
▼ -0.06 (-1.24%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$3.05B
Growth
-19.1%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.15Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.78
Change-1.24%
Shares Out637.12M
Market Cap$3.05B
52W Range2.85 - 7.98
Beta0.88
P/E-2.70
P/S204.74
P/B-31.61
P/FCF-9.07
EV/Sales156.02
EV/EBITDA-5.46
Price$4.78
Change-1.24%
Shares Out637.12M
Market Cap$3.05B
52W Range2.85 - 7.98
Beta0.88
P/E-2.70
P/S204.74
P/B-31.61
P/FCF-9.07
EV/Sales156.02
EV/EBITDA-5.46
EV/FCF-6.91
Earnings Yield-37.06%
FCF Yield-11.03%
Dividend Yield0.00%
Gross Margin33.68%
Oper. Margin-29.21%
Profit Margin-75.88%
Debt/Eq-2.05
Current Ratio3.15
Quick Ratio3.15
Revenue 5Y-19.10%
Target$15.33
Target Upside220.71%
Target Median$13.00
Target Range12.00 - 24.00
Volume1.01M
Avg Volume445.10K
EPS Surprise-0.84
Investment DNA
How strong this company looks for long-term investors
28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 3.15Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
88/100
Bullish
Bullish
7
Hold
0
Bearish
1
Price Target
2026-06-15
Low
$12.00
Mean
$16.50
Median
$15.00
High
$24.00
🧾
No insider activity
No recent insider transactions available.